Botanix Pharmaceuticals Limited (ASX:BOT) Directors Insider Transactions



The Directors and Chief Executives of Botanix Pharmaceuticals Limited (ASX:BOT) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Botanix Pharmaceuticals Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Botanix Pharmaceuticals Limited to the ASX stock exchange.

An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.

Botanix Pharmaceuticals Limited Directors/Insider Transactions Activity

List of Insider trades activity from Botanix Pharmaceuticals Limited (BOT).

Date Director Director's Title Shares Value Note
30 Jun 2025 McKibbon (Howie) Chief Executive Officer 7,313,391 - -
23 May 2025 Callahan (Matthew) Former 74,586,791 - -
20 Mar 2025 Sharp (Daniel) Director (Non-Executive) 3,111,145 - -
27 Feb 2025 Washer (Stewart James) Director (Non-Executive) 3,990,099 253,371 Purchase at price 0.06 per share.
15 Jan 2025 Ippolito Vincent P Executive Chairman 3,800,000 1,040,820 Other at price 0.27 per share.
08 Jan 2025 Ippolito Vincent P Executive Chairman 8,000,000 - -